Viridian Therapeutics (VRDN) Stock Chart & Stock Price History $18.87 -0.78 (-3.97%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$18.87 0.00 (0.00%) As of 09/12/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viridian Therapeutics Stock Price Performance The Viridian Therapeutics (VRDN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 14.46%, with a year-to-date return of -1.56%. In the past month, the stock has increased 0.11%, reflecting recent market activity. As of the latest close, Viridian Therapeutics traded at $18.87 with a market cap of $1.54 billion and volume of 448,146 shares. Receive VRDN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-4.75%1 Month Performance+0.11%3 Month Performance+18.83%Year-To-Date Performance-1.56%1 Year Performance-14.46% VRDN Stock Chart for Saturday, September, 13, 2025 VRDN Chart by TradingView Viridian Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/12/2025$19.65$18.87-3.97%$19.57$18.86448,146 shs$1.54 billion09/11/2025$19.82$19.65-0.86%$20.34$19.48467,250 shs$1.60 billion09/10/2025$20.21$19.82-1.93%$20.51$19.67924,885 shs$1.62 billion09/09/2025$19.81$20.21+2.02%$20.23$19.441.18 million shs$1.65 billion09/08/2025$18.72$19.81+5.82%$19.82$18.63741,731 shs$1.62 billion09/05/2025$18.64$18.72+0.43%$19.08$18.31799,775 shs$1.53 billion09/04/2025$19.47$18.64-4.26%$19.67$18.12866,584 shs$1.52 billion09/03/2025$19.14$19.47+1.72%$20.05$18.721.10 million shs$1.59 billion09/02/2025$18.38$19.14+4.13%$19.29$18.371.49 million shs$1.56 billion09/01/2025$18.38$18.38$18.58$18.00649,738 shs$1.50 billion Get the Latest News and Ratings for VRDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/29/2025$18.44$18.38-0.33%$18.58$18.00649,738 shs$1.50 billion08/28/2025$18.56$18.44-0.65%$19.09$18.23485,387 shs$1.51 billion08/27/2025$18.66$18.56-0.54%$18.85$18.25522,453 shs$1.52 billion08/26/2025$18.57$18.66+0.48%$19.15$18.22739,527 shs$1.52 billion08/25/2025$19.23$18.57-3.43%$19.73$18.54771,384 shs$1.52 billion08/22/2025$18.02$19.23+6.71%$19.60$17.991.40 million shs$1.57 billion08/21/2025$18.14$18.02-0.66%$18.29$17.50630,368 shs$1.47 billion08/20/2025$17.81$18.14+1.85%$18.39$17.38730,422 shs$1.48 billion08/19/2025$18.11$17.81-1.66%$18.17$17.041.88 million shs$1.45 billion08/18/2025$18.54$18.11-2.32%$18.96$17.96654,025 shs$1.48 billion08/15/2025$18.44$18.54+0.54%$18.56$17.67891,715 shs$1.51 billion08/14/2025$18.85$18.44-2.18%$18.86$18.11449,068 shs$1.51 billion08/13/2025$17.97$18.85+4.90%$19.10$18.061.07 million shs$1.54 billion08/12/2025$16.89$17.97+6.39%$18.04$16.95923,890 shs$1.47 billion08/11/2025$16.41$16.89+2.93%$16.91$16.02758,148 shs$1.38 billion Related Companies RDNT Stock Chart OPCH Stock Chart SHC Stock Chart BTSG Stock Chart WGS Stock Chart CON Stock Chart SGRY Stock Chart PRVA Stock Chart VCYT Stock Chart HTFL Stock Chart Receive VRDN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRDN) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
